China Focuses On Pregnant Women To Reduce Future Diabetes
This article was originally published in PharmAsia News
China faces 100 million people with diabetes, 10% of adults, at a cost of $26 billion, leading to an effort by health authorities to reduce the causes
You may also be interested in...
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.